Stock Scorecard
Stock Summary for Zimmer Biomet Holdings Inc (ZBH) - $99.17 as of 10/3/2025 3:36:43 PM EST
Total Score
9 out of 30
Safety Score
61 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ZBH
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ZBH
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ZBH
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ZBH
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ZBH (61 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 9 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 1 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 8 |
| Price to Earnings (Max of 10) | 7 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for ZBH
Financial Details for ZBH
Company Overview |
|
|---|---|
| Ticker | ZBH |
| Company Name | Zimmer Biomet Holdings Inc |
| Country | USA |
| Description | Zimmer Biomet Holdings Inc. is a leading global medical device company focused on the design, manufacture, and marketing of a comprehensive portfolio of orthopedic reconstructive products, surgical and non-surgical solutions, and related services. Headquartered in Warsaw, Indiana, the company leverages a robust innovation pipeline and strategic partnerships to enhance patient outcomes and drive growth in the orthopedic, surgical, and dental markets. Zimmer Biomet’s commitment to innovation and excellence positions it as a key player in the healthcare industry, addressing the evolving needs of surgeons and healthcare professionals worldwide. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 10/30/2025 |
Stock Price History |
|
| Last Day Price | 99.17 |
| Price 4 Years Ago | 119.50 |
| Last Day Price Updated | 10/3/2025 3:36:43 PM EST |
| Last Day Volume | 893,405 |
| Average Daily Volume | 1,351,794 |
| 52-Week High | 113.87 |
| 52-Week Low | 88.77 |
| Last Price to 52 Week Low | 11.72% |
Valuation Measures |
|
| Trailing PE | 24.58 |
| Industry PE | 43.82 |
| Sector PE | 41.81 |
| 5-Year Average PE | 17.73 |
| Free Cash Flow Ratio | 35.29 |
| Industry Free Cash Flow Ratio | 37.88 |
| Sector Free Cash Flow Ratio | 30.43 |
| Current Ratio Most Recent Quarter | 1.87 |
| Total Cash Per Share | 2.81 |
| Book Value Per Share Most Recent Quarter | 63.29 |
| Price to Book Ratio | 1.57 |
| Industry Price to Book Ratio | 3.99 |
| Sector Price to Book Ratio | 32.30 |
| Price to Sales Ratio Twelve Trailing Months | 2.55 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.48 |
| Sector Price to Sales Ratio Twelve Trailing Months | 20.26 |
| Analyst Buy Ratings | 6 |
| Analyst Strong Buy Ratings | 5 |
Share Statistics |
|
| Total Shares Outstanding | 198,096,000 |
| Market Capitalization | 19,645,180,320 |
| Institutional Ownership | 98.83% |
Dividends |
|
| Ex-Dividend Date | 9/30/2025 |
| Previous Dividend Amount | 0.2400 |
| Current Dividend Amount | 0.2400 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.96 |
| Trailing Annual Dividend Yield | 0.97% |
| Forward Annual Dividend Rate | 0.96 |
| Forward Annual Dividend Yield | 0.97% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 0.92% |
| 5-Year Average Dividend Yield | 0.82% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 2.43% |
| Dividend Payout Ratio | 23.41% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -34.70% |
| Annual Earnings Growth | -11.74% |
| Reported EPS 12 Trailing Months | 4.10 |
| Reported EPS Past Year | 3.88 |
| Reported EPS Prior Year | 8.00 |
| Net Income Twelve Trailing Months | 823,400,000 |
| Net Income Past Year | 903,800,000 |
| Net Income Prior Year | 1,024,000,000 |
| Quarterly Revenue Growth YOY | 7.00% |
| 5-Year Revenue Growth | -0.77% |
| Operating Margin Twelve Trailing Months | 19.50% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 556,900,000 |
| Total Cash Past Year | 525,500,000 |
| Total Cash Prior Year | 415,800,000 |
| Net Cash Position Most Recent Quarter | -6,195,600,000 |
| Net Cash Position Past Year | -4,816,100,000 |
| Long Term Debt Past Year | 5,341,600,000 |
| Long Term Debt Prior Year | 5,012,600,000 |
| Total Debt Most Recent Quarter | 6,752,500,000 |
| Equity to Debt Ratio Past Year | 0.70 |
| Equity to Debt Ratio Most Recent Quarter | 0.65 |
| Total Stockholder Equity Past Year | 12,468,100,000 |
| Total Stockholder Equity Prior Year | 12,480,500,000 |
| Total Stockholder Equity Most Recent Quarter | 12,525,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,423,900,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 7.19 |
| Free Cash Flow Past Year | 1,142,600,000 |
| Free Cash Flow Prior Year | 1,187,100,000 |
Options |
|
| Put/Call Ratio | 0.24 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.67 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 10/4/2025 1:01:10 PM EST |